The pRED French R&D Institute will be managed by a Roche academic team which will be in charge of building new research networks with French academic partners, leveraging their expertise, technology platforms and scientific breakthroughs in areas of medical need.
The Institute will serve for academic collaborations in France across multiple disease areas and scientific disciplines: oncology, neurosciences, metabolism, inflammation, virology, translational research and toxicology.
With the French R&D Institute, Roche adds another piece to its network of external ‘hubs,’ joining academic collaborations established in Singapore, Switzerland with Basel and Geneva, and the Netherlands.
Roche said the collaborative models with multiple investigators and universities aim at advancing biomedical research from the lab to the patient.
Roche pRED global head Jean-Jacques Garaud said the pRED French R&D Institute enablesthem to with France’s scientists in a common objective – accelerating the translation of early scientific discoveries into personalized treatments for patients.